Literature DB >> 17028374

The neurobiology of the tuberous sclerosis complex.

Leah Marcotte1, Peter B Crino.   

Abstract

Tuberous sclerosis complex (TSC) is a multisystem disorder that affects numerous organ systems. Brain lesions that form during development, known as tubers, are highly associated with epilepsy, cognitive disability, and autism. Following the identification of two genes and their encoded proteins, TSC1 (hamartin) and TSC2 (tuberin), responsible for TSC, identification of several downstream protein cascades that might be affected in TSC have been discovered. Of primary importance is the mammalian target of rapamycin pathway that controls cell growth and protein synthesis. The mechanisms governing brain lesion growth have not been fully identified but likely altered regulation of the mammalian target of rapamycin cascade by hamartin and tuberin during development leads to aberrant cell growth. Secondary effects of TSC gene mutations might disrupt normal neuronal migration and cerebral cortical lamination. Numerous studies have identified changes in gene and protein expression in animal models of TSC and in human TSC brain specimens that contribute to altered brain cytoarchitecture. This review will provide an overview of the neurobiological aspects of TSC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028374     DOI: 10.1385/NMM:8:4:531

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  100 in total

1.  Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study.

Authors:  S H Park; S H Pepkowitz; C Kerfoot; M J De Rosa; V Poukens; R Wienecke; J E DeClue; H V Vinters
Journal:  Acta Neuropathol       Date:  1997-08       Impact factor: 17.088

2.  The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.

Authors:  M M Maheshwar; J P Cheadle; A C Jones; J Myring; A E Fryer; P C Harris; J R Sampson
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

3.  The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho.

Authors:  R F Lamb; C Roy; T J Diefenbach; H V Vinters; M W Johnson; D G Jay; A Hall
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

4.  Hamartin and tuberin expression in human tissues.

Authors:  M W Johnson; C Kerfoot; T Bushnell; M Li; H V Vinters
Journal:  Mod Pathol       Date:  2001-03       Impact factor: 7.842

5.  The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.

Authors:  T L Plank; H Logginidou; A Klein-Szanto; E P Henske
Journal:  Mod Pathol       Date:  1999-05       Impact factor: 7.842

6.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

Review 7.  Infantile spasms in tuberous sclerosis complex.

Authors:  P Curatolo; S Seri; M Verdecchia; R Bombardieri
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

8.  mTOR cascade activation distinguishes tubers from focal cortical dysplasia.

Authors:  Marianna Baybis; Jia Yu; Allana Lee; Jeff A Golden; Howard Weiner; Guy McKhann; Eleonora Aronica; Peter B Crino
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

View more
  15 in total

1.  Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration.

Authors:  R Michelle Reith; Sharon Way; James McKenna; Katherine Haines; Michael J Gambello
Journal:  Neurobiol Dis       Date:  2011-03-17       Impact factor: 5.996

Review 2.  Phosphatidylinositol 3-kinase: the oncoprotein.

Authors:  Peter K Vogt; Jonathan R Hart; Marco Gymnopoulos; Hao Jiang; Sohye Kang; Andreas G Bader; Li Zhao; Adam Denley
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle.

Authors:  Jing Zhou; Gayatri Shrikhande; Jing Xu; Renée M McKay; Dennis K Burns; Jane E Johnson; Luis F Parada
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

4.  Loss of the TOR kinase Tor2 mimics nitrogen starvation and activates the sexual development pathway in fission yeast.

Authors:  Tomohiko Matsuo; Yoko Otsubo; Jun Urano; Fuyuhiko Tamanoi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2007-01-29       Impact factor: 4.272

5.  Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events.

Authors:  Wei Qin; Jennifer A Chan; Harry V Vinters; Gary W Mathern; David N Franz; Bruce E Taillon; Pascal Bouffard; David J Kwiatkowski
Journal:  Brain Pathol       Date:  2010-07-13       Impact factor: 6.508

6.  Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.

Authors:  Lynsey Meikle; Kristen Pollizzi; Anna Egnor; Ioannis Kramvis; Heidi Lane; Mustafa Sahin; David J Kwiatkowski
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

Review 7.  mTOR signaling in neural stem cells: from basic biology to disease.

Authors:  Laura Magri; Rossella Galli
Journal:  Cell Mol Life Sci       Date:  2012-11-04       Impact factor: 9.261

Review 8.  Rates and predictors of seizure freedom in resective epilepsy surgery: an update.

Authors:  Dario J Englot; Edward F Chang
Journal:  Neurosurg Rev       Date:  2014-02-05       Impact factor: 3.042

9.  Fetal brain mTOR signaling activation in tuberous sclerosis complex.

Authors:  Victoria Tsai; Whitney E Parker; Ksenia A Orlova; Marianna Baybis; Anthony W S Chi; Benjamin D Berg; Jacqueline F Birnbaum; Jacqueline Estevez; Kei Okochi; Harvey B Sarnat; Laura Flores-Sarnat; Eleonora Aronica; Peter B Crino
Journal:  Cereb Cortex       Date:  2012-10-18       Impact factor: 5.357

10.  G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling.

Authors:  Mirja Tamara Prentzell; Ulrike Rehbein; Marti Cadena Sandoval; Ann-Sofie De Meulemeester; Ralf Baumeister; Laura Brohée; Bianca Berdel; Mathias Bockwoldt; Bernadette Carroll; Suvagata Roy Chowdhury; Andreas von Deimling; Constantinos Demetriades; Gianluca Figlia; Mariana Eca Guimaraes de Araujo; Alexander M Heberle; Ines Heiland; Birgit Holzwarth; Lukas A Huber; Jacek Jaworski; Magdalena Kedra; Katharina Kern; Andrii Kopach; Viktor I Korolchuk; Ineke van 't Land-Kuper; Matylda Macias; Mark Nellist; Wilhelm Palm; Stefan Pusch; Jose Miguel Ramos Pittol; Michèle Reil; Anja Reintjes; Friederike Reuter; Julian R Sampson; Chloë Scheldeman; Aleksandra Siekierska; Eduard Stefan; Aurelio A Teleman; Laura E Thomas; Omar Torres-Quesada; Saskia Trump; Hannah D West; Peter de Witte; Sandra Woltering; Teodor E Yordanov; Justyna Zmorzynska; Christiane A Opitz; Kathrin Thedieck
Journal:  Cell       Date:  2021-01-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.